Advent International to pick up 50.1% in Suven Pharma for Rs 6,313 Cr
The buyout is part of the private equity firm’s plan to create a contract drug manufacturing powerhouse in India
Suven Pharma | 27/12/2022 | By Sudeep Soparkar | 402
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy